EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Application of Nanotechnology in Thrombus Therapy

Shuyin Zhou, Wenbo Zhao iD, Jinglei Hu, Chun Mao, Min Zhou

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202202578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Shuyin Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal Un…. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Thrombosis. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 217 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A thrombus is a blood clot that forms in the lumen of an artery or vein, restricting blood flow and causing clinical symptoms. Thrombosis is associated with many life‐threatening cardiovascular diseases. However, current clinical therapeutic technologies still have many problems in targeting, enrichment, penetration, and safety to meet the thrombosis treatment needs. Therefore, researchers devote themselves to developing nanosystems loaded with antithrombotic drugs to address this paradox in recent years. Herein, the existing thrombosis treatment technologies are first reviewed; and then, their advantages and disadvantages are outlined based on a brief discussion of thrombosis's definition and formation mechanism. Furthermore, the need and application cases for introducing nanotechnology are discussed, focusing on thrombus‐specific targeted ligand modification technology and microenvironment‐triggered responsive drug release technology. Then, nanomaterials that can be used to design antithrombotic nanotherapeutic systems are summarized. Moreover, a variety of drug delivery technologies driven by nanomotors in thrombosis therapy is also introduced. Last of all, a prospective discussion on the future development of nanotechnology for thrombosis therapy is highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrinolytic AgentsThrombosisHumansProspective StudiesNanotechnologyDrug Delivery Systems

Stichwörter der Autor:innen

application of nanotechnologyprospectstherapeutic methodsthrombus

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China.
  • Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
  • Kuang Yaming Honors School, Nanjing University, Nanjing, 210023, China.

ORCID-Profile: Wenbo Zhao

Zitieren

APA

Zhou, S., Zhao, W., Hu, J., Mao, C., & Zhou, M. (2023). Application of Nanotechnology in Thrombus Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202578

Vancouver

Zhou S, Zhao W, Hu J, Mao C, Zhou M. Application of Nanotechnology in Thrombus Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202578

BibTeX
@article{Zhou2023,
  author = {Zhou, Shuyin and Zhao, Wenbo and Hu, Jinglei and Mao, Chun and Zhou, Min},
  title = {Application of Nanotechnology in Thrombus Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202202578}
}
Kostenlos starten →